Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

UNH shares have plunged YTD, but regulatory risks, cost pressures and earnings downgrades keep it far from a bargain.

UNH's CEO pledges reform after rare earnings miss as rising Medicare Advantage costs squeeze margins and spook investors.

Winnebago Industries said it expects to adjust its headcount, shift production plans and post weaker-than-expected results for the spring quarter due to eroding demand for motorhomes. U.K. Fintech ...

The changes would limit how insurers add patient diagnoses that trigger lucrative extra payments.

Bernstein SocGen Group analysts reiterated an ‘Outperform’ rating on Humana Inc. (NYSE:HUM) and a $313 price target. The ...